Kairos Pharma, Ltd. (KAPA) Stock Research

Over a week ago

Kairos Pharma announces collaboration with Bayer to enhance XOFIGO

Jul 22, 8:39 AM

Kairos Pharma announces interim safety data from Phase 1 trial of ENV-105

Jul 15, 8:33 AM

Kairos Pharma issues letter from CEO that recaps year, details plans for 2026

Jun 4, 8:13 AM

Kairos Pharma to acquire CL-273 from Celyn Therapeutics

Mar 2, 6:41 AM

Kairos Pharma to acquire to two clinical-stage oncology assets from Celyn

Feb 26, 9:11 AM

Kairos Pharma files $75M mixed securities shelf

Jan 13, 6:02 AM

Kairos Pharma announces interim efficacy analysis of ENV105

Sep 18, 8:12 AM

No more stories